Patients
were able to have up to 5 supplemental
sessions with family members
and/or significant others. A psychiatrist
saw patients to monitor the dose
of medication, adverse effects, and general
medical status. Therapy sessions
were audiotaped and reviewed by 2 of
the authors (K.M.P. and M.J.D.) to assess
treatment fidelity and adherence.
Blood samples were obtained every 3
months for determination of plasma levels
of fluoxetine and nor-fluoxetine.